Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Cheng Qin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100576966. Sources: OpenAlex.

Their work

Papers
8 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 8

  1. Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13402-026-01251-0↗
  2. Effect of TGFβ-ITGB6 feedback loop on liver metastasis in SMAD4 wild-type pancreatic cancer. First author DOI 10.1097/cm9.0000000000003722↗
  3. Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma. First author DOI 10.1186/s40364-026-00988-y↗
  4. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets. First author DOI 10.1016/j.bbcan.2024.189183↗
  5. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. Co-author DOI 10.1016/j.heliyon.2023.e20464↗
  6. Pancreatic cancer stemness: dynamic status in malignant progression. First author DOI 10.1186/s13046-023-02693-2↗
  7. Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer. First author DOI 10.3389/fonc.2022.910678↗
  8. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Co-author DOI 10.1186/s12943-020-01169-7↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zeru Li · 7 shared papers, 2022–2026 · strength 1.72
  2. Bangbo Zhao · 6 shared papers, 2022–2026 · strength 1.43
  3. Weibin Wang · 6 shared papers, 2020–2026 · strength 1.41
  4. Yutong Zhao · 3 shared papers, 2026 · strength 0.96
  5. Xiaoying Yang · 3 shared papers, 2022–2023 · strength 0.53
  6. Yuanyang Wang · 3 shared papers, 2022–2023 · strength 0.53
  7. Yutong Zhao · 2 shared papers, 2023–2024 · strength 0.42
  8. Weibin Wang · 2 shared papers, 2023–2024 · strength 0.42
  9. Haoyu Shi · 1 shared paper, 2026 · strength 0.32
  10. Xiangyu Zhang · 1 shared paper, 2026 · strength 0.29
  11. Yiping Xie · 1 shared paper, 2026 · strength 0.29
  12. Haoyu Shi · 1 shared paper, 2026 · strength 0.29
  13. Lin Chen · 1 shared paper, 2024 · strength 0.23
  14. Tianyu Li · 1 shared paper, 2024 · strength 0.23
  15. Tianyu Li · 1 shared paper, 2023 · strength 0.19
  16. Xingtong Zhou · 1 shared paper, 2023 · strength 0.17
  17. Tianhao Li · 1 shared paper, 2023 · strength 0.17
  18. Tianhao Li · 1 shared paper, 2022 · strength 0.16
  19. Bo Ren · 1 shared paper, 2020 · strength 0.11
  20. Gang Yang · 1 shared paper, 2020 · strength 0.11
  21. Fangyu Zhao · 1 shared paper, 2020 · strength 0.11
  22. Jinshou Yang · 1 shared paper, 2020 · strength 0.11
  23. Guangyu Chen · 1 shared paper, 2020 · strength 0.11
  24. Yupei Zhao · 1 shared paper, 2020 · strength 0.11
  25. Lei You · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.